| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 40.165 | 79.717 | 84.385 | 95.198 |
| Total Income - EUR | - | - | - | - | - | - | 40.335 | 79.719 | 84.386 | 95.210 |
| Total Expenses - EUR | - | - | - | - | - | - | 14.759 | 36.209 | 60.618 | 44.990 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 25.576 | 43.509 | 23.768 | 50.220 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 24.390 | 41.841 | 22.941 | 47.421 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Exya Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 178 | 2.584 | 12.927 | 9.905 |
| Current Assets | - | - | - | - | - | - | 26.418 | 41.642 | 18.987 | 60.946 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 24.734 | 22.402 | 6.122 | 60 |
| Cash | - | - | - | - | - | - | 1.684 | 19.240 | 12.865 | 60.886 |
| Shareholders Funds | - | - | - | - | - | - | 25.401 | 43.057 | 24.154 | 48.627 |
| Social Capital | - | - | - | - | - | - | 1.011 | 1.014 | 1.011 | 1.005 |
| Debts | - | - | - | - | - | - | 1.195 | 1.169 | 7.760 | 22.275 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Exya Med S.r.l.